{'fraction_non_alphanumeric': 0.023054755043227664, 'fraction_numerical': 0.01585014409221902, 'mean_word_length': 4.910638297872341, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
HNF3 binds and activates the second enhancer, ENII, of hepatitis B virus.

The basic functional unit of hepatitus B virus (HBV) enhancer II (ENII) is located within nt 1687-1774, which is defined as the B fragment in our previous papers. A major trans-acting factor binding site has been identified within the B fragment. The sequence corresponding to this binding site was named B2. In this paper, several point mutations were introduced into the B2 subunit by PCR-mediated site-directed mutagenesis. CAT analysis indicated that the TGTTTGTTT motif within the B2 subunit was critical for the activity of ENII. Mutations of individual nucleotides within this motif could decrease the activity of ENII. Electrophoresis mobility shift assay revealed that the liver-enriched transcription factors hepatocyte nuclear factor (HNF) 3 alpha and HNF3 beta bound to the B2 subunit specifically and the TGTTTGTTT motif was essential for DNA-protein interaction. Anti-HNF3 alpha and anti-HNF3 beta antisera could block such binding ability. Moreover, HNF3 beta could switch on the activity of ENII in HeLa cells and the activity of ENII could be suppressed by antisense HNF3 alpha and antisense HNF3 beta mRNA in HepG2 cells. These results prompted the conclusion that HNF3 was crucial for the liver-specific activity of ENII, which in turn contributed significantly to the liver specificity of HBV.